Company / Working Capital per Share
Kura Oncology, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$7.56
FY2025
5-year range
$5.42 / $8.96
FY2021-FY2025
Trend
-15.6%
vs FY2024
Sector context
#68 of 210
Health Care
What the data says
At $7.56, Kura Oncology, Inc.'s working capital per share ranks #68 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $3.39 in FY2016 to $11.52 in FY2020.
Based on SEC 10-K filings.
7.56 in FY2025 with a 5-year CAGR of -8.1%.
Improved from $5.42 to $7.56 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +6.3%
- 5-Year CAGR
- -8.1%
- 10-Year CAGR
- -
Sector benchmark
#68 of 210 in Health CareTop 32% of 210This company $7.56 Sector average $146.86
▼
-94.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 15.6% year-over-year.
- Ranks #68 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.56 | -15.6% |
| FY2024 | $8.96 | +65.2% |
| FY2023 | $5.42 | -14.0% |
| FY2022 | $6.30 | -16.3% |
| FY2021 | $7.53 | -34.6% |
| FY2020 | $11.52 | +115.6% |
| FY2019 | $5.34 | +12.2% |
| FY2018 | $4.76 | +30.8% |
| FY2017 | $3.64 | +7.5% |
| FY2016 | $3.39 | -58.9% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026